Shattuck Labs Announces Participation in Upcoming November Conferences
AUSTIN, TX and DURHAM, NC, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology...
Cancer
IO Biotech Announces New Clinical Collaboration with Merck to Evaluate Neoadjuvant and Adjuvant IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) in a Phase 2, Multi-cohort Trial in Patients with Resectable Tumors
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer...
Galecto to Participate in Jefferies London Healthcare Conference
BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and a world leader in...
CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10
BERKELEY HEIGHTS, N.J. , Nov. 02, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing...
Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
FREMONT, CA, Nov. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
SELLAS Life Sciences Provides Webcast Information for Phase 3 REGAL Study Update on November 14, 2022
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage...
Eterna Therapeutics Announces Research Collaboration to Develop Advanced Gene-Edited iPS Cell Therapies
SAN DIEGO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company...
Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
Activated multiple existing and new sites under amended Phase 1b breast cancer clinical trial protocol; additional site activations anticipated in...
Candel Therapeutics Upcoming Investor Conference Participation for November
NEEDHAM, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company developing novel...
Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2022, Hosted by the AASLD
Prevalence of esophageal and gastric varices in patients with compensated NASH cirrhosis and portal hypertensionBiochemical and imaging profiles in 271...
CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
Panbela Schedules Conference Call on, November 10, 2022, to Report 2022 Third Quarter Financial Results
MINNEAPOLIS, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...
Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on Form S-4, Date of Vickers Vantage Extraordinary General Meeting to Approve Proposed Business Combination
SEC declared Effectiveness of Vickers’s registration statement on Form S-4Extraordinary General Meeting of Vickers Vantage Corp. I shareholders to approve...
David Kessel Recognized with Gold Medal Award by the International Photodynamic Association
NANCY, France, Oct. 31, 2022 (GLOBE NEWSWIRE) -- The International Photodynamic Association (IPA) is pleased to announce that David Kessel,...
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
Sets company up to realize full commercial potential in fast growing U.S. marketSupports mutually beneficial interests between Biofrontera Inc and...
Tayyaba Hasan recognized with Gold Medal Award by the International Photodynamic Association
NANCY, France, Oct. 31, 2022 (GLOBE NEWSWIRE) -- The International Photodynamic Association (IPA) is pleased to announce that Professor Tayyaba...
Elena Filonenko Recognized with the Significant Advancement of PDT Award by the International Photodynamic Association
NANCY, France, Oct. 31, 2022 (GLOBE NEWSWIRE) -- The International Photodynamic Association (IPA) is pleased to announce that Professor Elena...
Xiuli Wang Recognized with Clinical PDT Research Excellence Award by the International Photodynamic Association
NANCY, France, Oct. 31, 2022 (GLOBE NEWSWIRE) -- The International Photodynamic Association (IPA) is pleased to announce that Professor Xiuli...
Heidi Abrahamse Recognized with Basic PDT Research Excellence Award by the International Photodynamic Association
Heidi Abrahamse Photo of Professor Heidi Abrahamse, recipient of the 2022 PDT Research Excellence AwardNANCY, France, Oct. 31, 2022 (GLOBE...
Anne-Laure Bulin Recognized with Early Investigator Award by the International Photodynamic Association
Anne-Laure Bulin Anne-Laure Bulin receives the 2022 Early Investigator AwardNANCY, France, Oct. 31, 2022 (GLOBE NEWSWIRE) -- The International Photodynamic...